A Small-Molecule PARP7 Inhibitor Triggers Antitumor Immunity

Article navigation

Research Watch| September 01 2021

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2021

American Association for Cancer Research.

Cancer Discov (2021) 11 (9): 2125.

Abstract

A small-molecule PARP7 inhibitor caused in vivo tumor regression by restoring interferon signaling.

2021

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.